Tjalf Ziemssen (T Ziemssen)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 137

Top Venues

Vaccines

Proceedings of the National Academy of Sciences of the United States of America

Brain sciences

Therapeutic advances in neurological disorders

University Hospital Carl Gustav Carus

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospital Carl Gustav Carus

Germany

Director :: Center of Clinical Neuroscience

Publications

Tammy Jiang, Mathura Shanmugasundaram, Ivan Božin, Mark S Freedman, James B Lewin, Changyu Shen, Tjalf Ziemssen, Douglas L Arnold
Comparative efficacy of diroximel fumarate, ozanimod and interferon beta-1a for relapsing multiple sclerosis using matching-adjusted indirect comparisons. Journal of comparative effectiveness research (2024)
Hernan Inojosa, Dirk Schriefer, Yassin Atta, Anja Dillenseger, Undine Proschmann, Katharina Schleußner, Christina Woopen, Tjalf Ziemssen, Katja Akgün
Insights from Real-World Practice: The Dynamics of SARS-CoV-2 Infections and Vaccinations in a Large German Multiple Sclerosis Cohort. Vaccines 12 (3) (2024)
Tjalf Ziemssen, Marie Groth, Veronika Eva Winkelmann, Tobias Bopp
Correction: Ziemssen et al. Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod-Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC). Vaccines 2023, 11 , 1374. Vaccines 12 (8) (2024)
Georges Katoul Al Rahbani, Christina Woopen, Marie Dunsche, Undine Proschmann, Tjalf Ziemssen, Katja Akgün
SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma. Vaccines 12 (6) (2024)
Barry A Singer, Sibyl Wray, Mark Gudesblatt, Barbara Bumstead, Tjalf Ziemssen, Ashley Bonnell, Matthew Scaramozza, Seth Levin, Mathura Shanmugasundaram, Hailu Chen, Jason P Mendoza, James B Lewin, Sai L Shankar
Lymphopenia is Not the Primary Therapeutic Mechanism of Diroximel Fumarate in Relapsing-Remitting Multiple Sclerosis: Subgroup Analyses of the EVOLVE-MS-1 Study. Neurology and therapy (2024)
Hernan Inojosa, Dirk Schriefer, Yassin Atta, Anja Dillenseger, Undine Proschmann, Katharina Schleußner, Christina Woopen, Tjalf Ziemssen, Katja Akgün
Insights from Real-World Practice: The Dynamics of SARS-CoV-2 Infections and Vaccinations in a Large German Multiple Sclerosis Cohort. Vaccines 12 (3) (2024)
Anne Geßner, Maximilian Hartmann, Katrin Trentzsch, Heidi Stölzer-Hutsch, Dirk Schriefer, Tjalf Ziemssen
The Association of Age, Sex, and BMI on Lower Limb Neuromuscular and Muscle Mechanical Function in People with Multiple Sclerosis. Biomedicines 12 (5) (2024)
Steffeni Papukchieva, Maria Kahn, Markus Eberl, Benjamin Friedrich, Natalie Joschko, Tjalf Ziemssen
Data on Ocrelizumab Treatment Collected by MS Patients in Germany Using Brisa App. Journal of personalized medicine 14 (4) (2024)
Steffeni Papukchieva, Maria Kahn, Markus Eberl, Benjamin Friedrich, Natalie Joschko, Tjalf Ziemssen
Data on Ocrelizumab Treatment Collected by MS Patients in Germany Using Brisa App. Journal of personalized medicine 14 (4) (2024)
Julia Feige, Tobias Moser, Katja Akgün, Kerstin Schwenker, Wolfgang Hitzl, Elisabeth Haschke-Becher, Tjalf Ziemssen, Johann Sellner
Repeated iv anti-CD20 treatment in multiple sclerosis: Long-term effects on peripheral immune cell subsets. Annals of clinical and translational neurology 11 (2) (2024)
Georges Katoul Al Rahbani, Christina Woopen, Marie Dunsche, Undine Proschmann, Tjalf Ziemssen, Katja Akgün
SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma. Vaccines 12 (6) (2024)
Georges Katoul Al Rahbani, Christina Woopen, Marie Dunsche, Undine Proschmann, Tjalf Ziemssen, Katja Akgün
SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma. Vaccines 12 (6) (2024)
Tony Sehr, Katja Akgün, Pascal Benkert, Jens Kuhle, Tjalf Ziemssen, Moritz D Brandt
Effects of obstructive sleep apnea treatment on neurodegenerative biomarker neurofilament light chain and cognitive performance. Journal of sleep research (2024)
Barry A Singer, Sibyl Wray, Mark Gudesblatt, Barbara Bumstead, Tjalf Ziemssen, Ashley Bonnell, Matthew Scaramozza, Seth Levin, Mathura Shanmugasundaram, Hailu Chen, Jason P Mendoza, James B Lewin, Sai L Shankar
Lymphopenia is Not the Primary Therapeutic Mechanism of Diroximel Fumarate in Relapsing-Remitting Multiple Sclerosis: Subgroup Analyses of the EVOLVE-MS-1 Study. Neurology and therapy 13 (4) (2024)
Julia Feige, Tobias Moser, Katja Akgün, Kerstin Schwenker, Wolfgang Hitzl, Elisabeth Haschke-Becher, Tjalf Ziemssen, Johann Sellner
Repeated iv anti-CD20 treatment in multiple sclerosis: Long-term effects on peripheral immune cell subsets. Annals of clinical and translational neurology (2024)
Hernan Inojosa, Dirk Schriefer, Yassin Atta, Anja Dillenseger, Undine Proschmann, Katharina Schleußner, Christina Woopen, Tjalf Ziemssen, Katja Akgün
Insights from Real-World Practice: The Dynamics of SARS-CoV-2 Infections and Vaccinations in a Large German Multiple Sclerosis Cohort. Vaccines 12 (3) (2024)
Martin Nötzel, Maria Mahamid, Romy Kronstein-Wiedemann, Tjalf Ziemssen, Katja Akgün
Raman Spectroscopy of Optically Trapped Living Human T Cell Subsets and Monocytes. International journal of molecular sciences 25 (17) (2024)
Julia Feige, Tobias Moser, Katja Akgün, Kerstin Schwenker, Wolfgang Hitzl, Elisabeth Haschke-Becher, Tjalf Ziemssen, Johann Sellner
Repeated iv anti-CD20 treatment in multiple sclerosis: Long-term effects on peripheral immune cell subsets. Annals of clinical and translational neurology 11 (2) (2024)
Julia Feige, Tobias Moser, Katja Akgün, Kerstin Schwenker, Wolfgang Hitzl, Elisabeth Haschke-Becher, Tjalf Ziemssen, Johann Sellner
Repeated iv anti-CD20 treatment in multiple sclerosis: Long-term effects on peripheral immune cell subsets. Annals of clinical and translational neurology 11 (2) (2024)
Julia Feige, Tobias Moser, Katja Akgün, Kerstin Schwenker, Wolfgang Hitzl, Elisabeth Haschke-Becher, Tjalf Ziemssen, Johann Sellner
Repeated iv anti-CD20 treatment in multiple sclerosis: Long-term effects on peripheral immune cell subsets. Annals of clinical and translational neurology 11 (2) (2024)
Barry A Singer, Sibyl Wray, Mark Gudesblatt, Barbara Bumstead, Tjalf Ziemssen, Ashley Bonnell, Matthew Scaramozza, Seth Levin, Mathura Shanmugasundaram, Hailu Chen, Jason P Mendoza, James B Lewin, Sai L Shankar
Lymphopenia is Not the Primary Therapeutic Mechanism of Diroximel Fumarate in Relapsing-Remitting Multiple Sclerosis: Subgroup Analyses of the EVOLVE-MS-1 Study. Neurology and therapy 13 (4) (2024)
Barry A Singer, Sibyl Wray, Mark Gudesblatt, Barbara Bumstead, Tjalf Ziemssen, Ashley Bonnell, Matthew Scaramozza, Seth Levin, Mathura Shanmugasundaram, Hailu Chen, Jason P Mendoza, James B Lewin, Sai L Shankar
Lymphopenia is Not the Primary Therapeutic Mechanism of Diroximel Fumarate in Relapsing-Remitting Multiple Sclerosis: Subgroup Analyses of the EVOLVE-MS-1 Study. Neurology and therapy 13 (4) (2024)
Anne Geßner, Maximilian Hartmann, Katrin Trentzsch, Heidi Stölzer-Hutsch, Dirk Schriefer, Tjalf Ziemssen
The Association of Age, Sex, and BMI on Lower Limb Neuromuscular and Muscle Mechanical Function in People with Multiple Sclerosis. Biomedicines 12 (5) (2024)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Marco Ghiani, Evi Zhuleku, Anja Dillenseger, Ulf Maywald, Andreas Fuchs, Thomas Wilke, Tjalf Ziemssen
Data Resource Profile: The Multiple Sclerosis Documentation System 3D and AOK PLUS Linked Database (MSDS-AOK PLUS). Journal of clinical medicine 12 (4) (2023)
Gavin Giovannoni, Enrique Alvarez, Ellen Tutton, Olaf Hoffmann, Yan Xu, Patrick Vermersch, Celia Oreja-Guevara, Maria Trojano, Ralf Gold, René Robles-Cedeño, Mudeer Khwaja, Bianca Stadler, Jo Vandercappellen, Tjalf Ziemssen
Development and usability testing of your MS questionnaire: A patient-based digital tool to monitor symptoms of multiple sclerosis. Digital health 9 (2023)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Anne Geßner, Heidi Stölzer-Hutsch, Katrin Trentzsch, Dirk Schriefer, Tjalf Ziemssen
Countermovement Jumps Detect Subtle Motor Deficits in People with Multiple Sclerosis below the Clinical Threshold. Biomedicines 11 (3) (2023)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Hernan Inojosa, Stephen Gilbert, Jakob Nikolas Kather, Undine Proschmann, Katja Akgün, Tjalf Ziemssen
Can ChatGPT explain it? Use of artificial intelligence in multiple sclerosis communication. Neurological research and practice 5 (1) (2023)
Tjalf Ziemssen, Eugen Schlegel, Marie Groth, Benjamin Ettle, Tobias Bopp
Results on SARS-CoV-2 mRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis. Vaccines 11 (5) (2023)
Gavin Giovannoni, Enrique Alvarez, Ellen Tutton, Olaf Hoffmann, Yan Xu, Patrick Vermersch, Celia Oreja-Guevara, Maria Trojano, Ralf Gold, René Robles-Cedeño, Mudeer Khwaja, Bianca Stadler, Jo Vandercappellen, Tjalf Ziemssen
Development and usability testing of your MS questionnaire: A patient-based digital tool to monitor symptoms of multiple sclerosis. Digital health 9 (2023)
Anne Geßner, Heidi Stölzer-Hutsch, Katrin Trentzsch, Dirk Schriefer, Tjalf Ziemssen
Countermovement Jumps Detect Subtle Motor Deficits in People with Multiple Sclerosis below the Clinical Threshold. Biomedicines 11 (3) (2023)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Marco Ghiani, Evi Zhuleku, Anja Dillenseger, Ulf Maywald, Andreas Fuchs, Thomas Wilke, Tjalf Ziemssen
Data Resource Profile: The Multiple Sclerosis Documentation System 3D and AOK PLUS Linked Database (MSDS-AOK PLUS). Journal of clinical medicine 12 (4) (2023)
Undine Proschmann, Puya Shalchi Amirkhiz, Pauline Andres, Rocco Haase, Hernan Inojosa, Tjalf Ziemssen, Katja Akgün
Influence of Pre-Analytic Conditions on Quantity of Lymphocytes. International journal of molecular sciences 24 (17) (2023)
Alasdair J Coles, Anat Achiron, Anthony Traboulsee, Barry A Singer, Carlo Pozzilli, Celia Oreja-Guevara, Gavin Giovannoni, Giancarlo Comi, Mark S Freedman, Tjalf Ziemssen, Debora Shiota, Andreea M Rawlings, Alana T Wong, Magdalena Chirieac, Xavier Montalban
Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study. Therapeutic advances in neurological disorders 16 (2023)
Christina Woopen, Marie Dunsche, Georges Katoul Al Rahbani, Anja Dillenseger, Yassin Atta, Rocco Haase, Catarina Raposo, Rosetta Pedotti, Tjalf Ziemssen, Katja Akgün
Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy. Vaccines 11 (9) (2023)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Colin M Dayan, Beatriz Lecumberri, Ilaria Muller, Sashiananthan Ganesananthan, Samuel F Hunter, Krzysztof W Selmaj, Hans-Peter Hartung, Eva K Havrdova, Christopher C LaGanke, Tjalf Ziemssen, Bart Van Wijmeersch, Sven G Meuth, David H Margolin, Elizabeth M Poole, Darren P Baker, Peter A Senior
Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies. Multiple sclerosis journal - experimental, translational and clinical 9 (1) (2023)
Undine Proschmann, Magdalena Mueller-Enz, Christina Woopen, Georges Katoul Al Rahbani, Rocco Haase, Anja Dillenseger, Marie Dunsche, Yassin Atta, Tjalf Ziemssen, Katja Akgün
Differential effects of selective versus unselective sphingosine 1-phosphate receptor modulators on T- and B-cell response to SARS-CoV-2 vaccination. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Marco Ghiani, Evi Zhuleku, Anja Dillenseger, Ulf Maywald, Andreas Fuchs, Thomas Wilke, Tjalf Ziemssen
Data Resource Profile: The Multiple Sclerosis Documentation System 3D and AOK PLUS Linked Database (MSDS-AOK PLUS). Journal of clinical medicine 12 (4) (2023)
Marco Ghiani, Evi Zhuleku, Anja Dillenseger, Ulf Maywald, Andreas Fuchs, Thomas Wilke, Tjalf Ziemssen
Data Resource Profile: The Multiple Sclerosis Documentation System 3D and AOK PLUS Linked Database (MSDS-AOK PLUS). Journal of clinical medicine 12 (4) (2023)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Barry A Singer, Douglas Lorne Arnold, Jelena S Drulovic, Mark S Freedman, Ralf Gold, Mark Gudesblatt, Elżbieta Jasińska, Christopher C LaGanke, Robert T Naismith, Donald Negroski, Jiwon Oh, Miguel Angel Hernandez Perez, Krzysztof Selmaj, Florian Then Bergh, Annette Wundes, Tjalf Ziemssen, Wanda Castro-Borrero, Hailu Chen, Seth Levin, Matthew Scaramozza, Sai L Shankar, Ting Wang, Sibyl Wray
Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Tjalf Ziemssen, Marie Groth, Veronika Eva Winkelmann, Tobias Bopp
Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod-Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC). Vaccines 11 (8) (2023)
Steffeni Mountford, Maria Kahn, Preetha Balakrishnan, Elizabeth Jacyshyn-Owen, Markus Eberl, Benjamin Friedrich, Natalie Joschko, Tjalf Ziemssen
Correlation and differences of patient-reported outcomes vs. Likert-Rating of MS symptoms in a real-world cohort using a digital patient app. Digital health 9 (2023)
Elias S Sotirchos, Chen Hu, Matthew D Smith, Hannah-Noelle Lord, Anna L DuVal, Georgina Arrambide, Xavier Montalban, Katja Akgün, Tjalf Ziemssen, Robert T Naismith, Carrie M Hersh, Megan Hyland, Lauren B Krupp, Jacqueline A Nicholas, Robert A Bermel, Ellen M Mowry, Peter A Calabresi, Kathryn C Fitzgerald
Agreement Between Published Reference Resources for Neurofilament Light Chain Levels in People With Multiple Sclerosis. Neurology (2023)
Leoné Malan, Roelof van Wyk, Roland von Känel, Tjalf Ziemssen, Walthard Vilser, Peter M Nilssson, Martin H Magnusson, Amra Jujić, Daniel Mak, Faans Steyn, Nico T Malan
The chronic stress risk phenotype mirrored in the human retina as a neurodegenerative condition. Stress (Amsterdam, Netherlands) (2023)
Tammy Jiang, Tjalf Ziemssen, Sibyl Wray, Changyu Shen, Karin Söderbärg, James B Lewin, Ivan Božin, Mark S Freedman
Matching-Adjusted Indirect Comparisons of Diroximel Fumarate, Ponesimod, and Teriflunomide for Relapsing Multiple Sclerosis. CNS drugs (2023)
Gavin Giovannoni, Enrique Alvarez, Ellen Tutton, Olaf Hoffmann, Yan Xu, Patrick Vermersch, Celia Oreja-Guevara, Maria Trojano, Ralf Gold, René Robles-Cedeño, Mudeer Khwaja, Bianca Stadler, Jo Vandercappellen, Tjalf Ziemssen
Development and usability testing of your MS questionnaire: A patient-based digital tool to monitor symptoms of multiple sclerosis. Digital health 9 (2023)
Colin M Dayan, Beatriz Lecumberri, Ilaria Muller, Sashiananthan Ganesananthan, Samuel F Hunter, Krzysztof W Selmaj, Hans-Peter Hartung, Eva K Havrdova, Christopher C LaGanke, Tjalf Ziemssen, Bart Van Wijmeersch, Sven G Meuth, David H Margolin, Elizabeth M Poole, Darren P Baker, Peter A Senior
Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies. Multiple sclerosis journal - experimental, translational and clinical 9 (1) (2023)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Tjalf Ziemssen, Marie Groth, Benjamin Ettle, Tobias Bopp
Immune Response to SARS-CoV-2 mRNA Vaccines in an Open-Label Multicenter Study in Participants with Relapsing Multiple Sclerosis Treated with Ofatumumab. Vaccines 10 (12) (2022)
Tjalf Ziemssen
Reader Response: NfL as Analogue of C-Reactive Protein in Neurologic Diseases: Instructions for Use. Neurology 99 (19) (2022)
Karsten Wendt, Katrin Trentzsch, Rocco Haase, Marie Luise Weidemann, Robin Weidemann, Uwe Aßmann, Tjalf Ziemssen
Transparent Quality Optimization for Machine Learning-Based Regression in Neurology. Journal of personalized medicine 12 (6) (2022)
Tjalf Ziemssen, Marie Groth, Benjamin Ettle, Tobias Bopp
Immune Response to SARS-CoV-2 mRNA Vaccines in an Open-Label Multicenter Study in Participants with Relapsing Multiple Sclerosis Treated with Ofatumumab. Vaccines 10 (12) (2022)
Tjalf Ziemssen, Michael Lang, Stephan Schmidt, Holger Albrecht, Luisa Klotz, Judith Haas, Christoph Lassek, Stefan Lang, Veronika E Winkelmann, Benjamin Ettle, Ulf Schulze-Topphoff, null null
Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany. Journal of neurology 269 (6) (2022)
Tjalf Ziemssen, Jo Vandercappellen, Valeria Jordan Mondragon, Gavin Giovannoni
MSProDiscuss™ Clinical Decision Support Tool for Identifying Multiple Sclerosis Progression. Journal of clinical medicine 11 (15) (2022)
Jeffrey A Cohen, Robert A Bermel, Cynthia I Grossman, Carrie M Hersh, Megan Hyland, Ellen M Mowry, Robert T Naismith, Maria L Naylor, Jacqueline Nicholas, Rajani Rajbhandar, Carol M Singh, Mar Tintore, Anna Zabalza, Tjalf Ziemssen, James R Williams, Xavier Montalban
Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions. Multiple sclerosis (Houndmills, Basingstoke, England) 28 (7) (2022)
Helmut Butzkueven, Paul S Giacomini, Stanley Cohan, Tjalf Ziemssen, Daniel Sienkiewicz, Ying Zhang, Yvonne Geissbühler, Diego Silva, Davorka Tomic, Harald Kropshofer, Maria Trojano
Safety of Fingolimod in Patients with Multiple Sclerosis Switched from Natalizumab: Results from TRANSITION-A 2-Year, Multicenter, Observational, Cohort Study. Brain sciences 12 (2) (2022)
Isabel Voigt, Christine Stadelmann, Sven G Meuth, Bernhard Schipp, Peter Flachenecker, Mathias Mäurer, Richard H W Funk, Franziska Ramisch, Joachim Niemeier, Tjalf Ziemssen
[New master's program: multiple sclerosis management]. Wiener medizinische Wochenschrift (1946) 172 (15-16) (2022)
Victor Constantinescu, Katja Akgün, Tjalf Ziemssen
Current status and new developments in sphingosine-1-phosphate receptor antagonism: fingolimod and more. Expert opinion on drug metabolism & toxicology 18 (10) (2022)
Paula Schumann, Maria Scholz, Katrin Trentzsch, Thurid Jochim, Grzegorz Śliwiński, Hagen Malberg, Tjalf Ziemssen
Detection of Fall Risk in Multiple Sclerosis by Gait Analysis-An Innovative Approach Using Feature Selection Ensemble and Machine Learning Algorithms. Brain sciences 12 (11) (2022)
Martin Nötzel, Luise Ina Werder, Tjalf Ziemssen, Katja Akgün
Ella versus Simoa Serum Neurofilament Assessment to Monitor Treatment Response in Highly Active Multiple Sclerosis Patients. International journal of molecular sciences 23 (20) (2022)
Victor Constantinescu, Rocco Haase, Katja Akgün, Tjalf Ziemssen
S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review. Therapeutic advances in neurological disorders 15 (2022)
Katja Akgün, Johanna Behrens, Dirk Schriefer, Tjalf Ziemssen
Acute Effects of Ocrelizumab Infusion in Multiple Sclerosis Patients. International journal of molecular sciences 23 (22) (2022)
Tjalf Ziemssen, Marie Groth, Benedict Rauser, Tobias Bopp
Assessing the immune response to SARS-CoV-2 mRNA vaccines in siponimod-treated patients: a nonrandomized controlled clinical trial (AMA-VACC). Therapeutic advances in neurological disorders 15 (2022)
Raymond Hupperts, Claudio Gasperini, Jan N Lycke, Tjalf Ziemssen, Peter Feys, Shan Xiao, Carlos Acosta, Thijs Koster, Jeremy Hobart
Efficacy of prolonged-release fampridine versus placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCE. Therapeutic advances in neurological disorders 15 (2022)
Tjalf Ziemssen, Marie Groth, Benjamin Ettle, Tobias Bopp
Immune Response to SARS-CoV-2 mRNA Vaccines in an Open-Label Multicenter Study in Participants with Relapsing Multiple Sclerosis Treated with Ofatumumab. Vaccines 10 (12) (2022)
Tjalf Ziemssen, Virender Bhan, Jeremy Chataway, Tanuja Chitnis, Bruce Anthony Campbell Cree, Eva Kubala Havrdova, Ludwig Kappos, Pierre Labauge, Aaron Miller, Jin Nakahara, Celia Oreja-Guevara, Jacqueline Palace, Barry Singer, Maria Trojano, Ashwini Patil, Benedict Rauser, Thomas Hach
Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying Therapies. Neurology(R) neuroimmunology & neuroinflammation 10 (1) (2022)
Hernan Inojosa, Undine Proschmann, Katja Akgün, Tjalf Ziemssen
The need for a strategic therapeutic approach: multiple sclerosis in check. Therapeutic advances in chronic disease 13 (2022)
Elias S Sotirchos, Kathryn C Fitzgerald, Carol M Singh, Matthew D Smith, Maria Reyes-Mantilla, Carrie M Hersh, Megan H Hyland, Ryan Canissario, Sarah B Simmons, Georgina Arrambide, Xavier Montalban, Manuel Comabella Lopez, Robert T Naismith, Min Qiao, Lauren B Krupp, Jacqueline A Nicholas, Katja Akgün, Tjalf Ziemssen, Richard Rudick, Elizabeth Fisher, Robert A Bermel, Ellen M Mowry, Peter A Calabresi
Associations of sNfL with clinico-radiological measures in a large MS population. Annals of clinical and translational neurology (2022)
Sven-Erik Sönksen, Sven Kühn, Mathias Basner, Darius Gerlach, Fabian Hoffmann, Christian Mühl, Jens Tank, Hans-Jürgen Noblé, Katja Akgün, Tjalf Ziemssen, Jens Jordan, Ulrich Limper
Brain structure and neurocognitive function in two professional mountaineers during 35 days of severe normobaric hypoxia. European journal of neurology 29 (10) (2022)
Dominik Koeditz, Juergen Frensch, Martin Bierbaum, Nils-Henning Ness, Benjamin Ettle, Umakanth Vudumula, Kapil Gudala, Nicholas Adlard, Santosh Tiwari, Tjalf Ziemssen
Comparing the long-term clinical and economic impact of ofatumumab versus dimethyl fumarate and glatiramer acetate in patients with relapsing multiple sclerosis: A cost-consequence analysis from a societal perspective in Germany. Multiple sclerosis journal - experimental, translational and clinical 8 (1) (2022)
Preetha Balakrishnan, Jannis Groenberg, Elizabeth Jacyshyn-Owen, Markus Eberl, Benjamin Friedrich, Natalie Joschko, Tjalf Ziemssen
Demographic Patterns of MS Patients Using BRISA: An MS-Specific App in Germany. Journal of personalized medicine 12 (7) (2022)
Christina Woopen, Marie Dunsche, Rocco Haase, Catarina Raposo, Rosetta Pedotti, Katja Akgün, Tjalf Ziemssen
Timing of SARS-CoV-2 Vaccination Matters in People With Multiple Sclerosis on Pulsed Anti-CD20 Treatment. Neurology(R) neuroimmunology & neuroinflammation 9 (6) (2022)
Maria Scholz, Rocco Haase, Dirk Schriefer, Isabel Voigt, Tjalf Ziemssen
Electronic Health Interventions in the Case of Multiple Sclerosis: From Theory to Practice. Brain sciences 11 (2) (2021)
Carrie M Hersh, Bernd Kieseier, Carl de Moor, Deborah M Miller, Denise Campagnolo, James R Williams, Kathryn C Fitzgerald, Kuangnan Xiong, Marisa P McGinley, Megan Hyland, Richard A Rudick, Tjalf Ziemssen, Irene Koulinska
Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: Results from MS PATHS. Multiple sclerosis journal - experimental, translational and clinical 7 (2) (2021)
Alasdair J Coles, Douglas L Arnold, Ann D Bass, Aaron L Boster, D Alastair S Compston, Óscar Fernández, Eva Kubala Havrdová, Kunio Nakamura, Anthony Traboulsee, Tjalf Ziemssen, Alan Jacobs, David H Margolin, Xiaobi Huang, Nadia Daizadeh, Madalina C Chirieac, Krzysztof W Selmaj
Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial. Therapeutic advances in neurological disorders 14 (2021)
Sabine Tacke, Stefan Braune, Damiano M Rovituso, Tjalf Ziemssen, Paul V Lehmann, Heidi Dikow, Arnfin Bergmann, Stefanie Kuerten
B-Cell Activity Predicts Response to Glatiramer Acetate and Interferon in Relapsing-Remitting Multiple Sclerosis. Neurology(R) neuroimmunology & neuroinflammation 8 (3) (2021)
Mengmeng Jin, Katja Akgün, Tjalf Ziemssen, Markus Kipp, Rene Günther, Andreas Hermann
Interleukin-17 and Th17 Lymphocytes Directly Impair Motoneuron Survival of Wildtype and FUS-ALS Mutant Human iPSCs. International journal of molecular sciences 22 (15) (2021)
Annette Wundes, Sibyl Wray, Ralf Gold, Barry A Singer, Elzbieta Jasinska, Tjalf Ziemssen, Jerome de Seze, Pavle Repovic, Hailu Chen, Jerome Hanna, Jordan Messer, Catherine Miller, Robert T Naismith
Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the randomized, double-blind, phase III EVOLVE-MS-2 study. Therapeutic advances in neurological disorders 14 (2021)
Tjalf Ziemssen, Ann D Bass, Regina Berkovich, Giancarlo Comi, Sara Eichau, Jeremy Hobart, Samuel F Hunter, Christopher LaGanke, Volker Limmroth, Daniel Pelletier, Carlo Pozzilli, Sven Schippling, Livia Sousa, Anthony Traboulsee, Bernard M J Uitdehaag, Bart Van Wijmeersch, Zia Choudhry, Nadia Daizadeh, Barry A Singer, null null
Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study. CNS drugs 34 (9) (2021)
Dirk Schriefer, Rocco Haase, Nils-Henning Ness, Tjalf Ziemssen
Cost of illness in multiple sclerosis by disease characteristics - A review of reviews. Expert review of pharmacoeconomics & outcomes research (2021)
Tjalf Ziemssen, Rocco Haase
Digital Innovation in Multiple Sclerosis Management. Brain sciences 12 (1) (2021)
Giancarlo Comi, Yuval Dadon, Nissim Sasson, Joshua R Steinerman, Volker Knappertz, Timothy L Vollmer, Alexey Boyko, Patrick Vermersch, Tjalf Ziemssen, Xavier Montalban, Fred D Lublin, Maria Assunta Rocca, Rita Volkinshtein, Svetlana Rubinchick, Nitsan Halevy, Massimo Filippi
CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (2021)
Lotte Geys, Tina Parciak, Ashkan Pirmani, Robert Nicholas McBurney, Hollie K Schmidt, Tanja Malbaša, Tjalf Ziemssen, Arnfin Bergmann, Juan I Rojas, Edgardo Cristiano, Juan Antonio García-Merino, Óscar Fernández, Jens Kuhle, Claudio Gobbi, Amber Delmas, Steve Simpson-Yap, Nupur Nag, Bassem Yamout, Nina Steinemann, Pierrette Seeldrayers, Bénédicte Dubois, Ingrid A van der Mei, Alexander Stahmann, Jelena Drulovic, Tatjana Pekmezovic, Waldemar Brola, Mar Tintore, Nynke Kalkers, Rumen Ivanov, Magd Zakaria, Maged Abdel Naseer, Wim Van Hecke, Nikolaos Grigoriadis, Marina Kleopatra Boziki, Adriana Carrá, Mikolaj A Pawlak, Ruth Dobson, Kerstin Hellwig, Arlene Gallagher, Letizia Leocani, Gloria Dalla Costa, Nise Alessandra de Carvalho Sousa, Bart Van Wijmeersch, Liesbet M Peeters
The Multiple Sclerosis Data Alliance Catalogue: Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources. International journal of MS care 23 (6) (2021)
Rocco Haase, Isabel Voigt, Maria Scholz, Hannes Schlieter, Martin Benedict, Marcel Susky, Anja Dillenseger, Tjalf Ziemssen
Profiles of eHealth Adoption in Persons with Multiple Sclerosis and Their Caregivers. Brain sciences 11 (8) (2021)
Anja Dillenseger, Marie Luise Weidemann, Katrin Trentzsch, Hernan Inojosa, Rocco Haase, Dirk Schriefer, Isabel Voigt, Maria Scholz, Katja Akgün, Tjalf Ziemssen
Digital Biomarkers in Multiple Sclerosis. Brain sciences 11 (11) (2021)
Tjalf Ziemssen, Ulf Schulze-Topphoff
The Change of Fingolimod Patient Profiles over Time: A Descriptive Analysis of Two Non-Interventional Studies PANGAEA and PANGAEA 2.0. Journal of personalized medicine 11 (6) (2021)
Tjalf Ziemssen, Anna Kurzeja, Bogdan Muresan, Jennifer S Haas, Jessica Alexander, Maurice T Driessen
Real-world patient characteristics, treatment patterns and costs in relapsing multiple sclerosis patients treated with glatiramer acetate, dimethyl fumarate or teriflunomide in Germany. Neurodegenerative disease management 12 (2) (2021)
Tobias Moser, Lena Hoepner, Kerstin Schwenker, Michael Seiberl, Julia Feige, Katja Akgün, Elisabeth Haschke-Becher, Tjalf Ziemssen, Johann Sellner
Cladribine Alters Immune Cell Surface Molecules for Adhesion and Costimulation: Further Insights to the Mode of Action in Multiple Sclerosis. Cells 10 (11) (2021)
Kevin Peikert, Hannes Glaß, Enrica Federti, Alessandro Matte, Lisann Pelzl, Katja Akgün, Tjalf Ziemssen, Rainer Ordemann, Florian Lang, The Network For Translational Research For Neuroacanthocytosis Patients, Lucia De Franceschi, Andreas Hermann
Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease. Journal of personalized medicine 11 (5) (2021)
Katrin Trentzsch, Paula Schumann, Grzegorz Śliwiński, Paul Bartscht, Rocco Haase, Dirk Schriefer, Andreas Zink, Andreas Heinke, Thurid Jochim, Hagen Malberg, Tjalf Ziemssen
Using Machine Learning Algorithms for Identifying Gait Parameters Suitable to Evaluate Subtle Changes in Gait in People with Multiple Sclerosis. Brain sciences 11 (8) (2021)
Stefanie Fischer, Undine Proschmann, Katja Akgün, Tjalf Ziemssen
Lymphocyte Counts and Multiple Sclerosis Therapeutics: Between Mechanisms of Action and Treatment-Limiting Side Effects. Cells 10 (11) (2021)
Tjalf Ziemssen, Gavin Giovannoni, Enrique Alvarez, Virender Bhan, Carrie M Hersh, Olaf Hoffmann, Celia Oreja-Guevara, Rene R Robles-Cedeño, Maria Trojano, Patrick Vermersch, Maria Pamela Dobay, Mudeer Khwaja, Bianca Stadler, Benedict Rauser, Thomas Hach, Daniela Piani-Meier, Jason Burton
Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey. Journal of medical Internet research 23 (10) (2021)

Tjalf Ziemssen.css-eqlu8i{font-size:small;padding-left:4px;} (T Ziemssen)

Publication Activity (10 Years)

Top Topics

Top Venues

Tjalf Ziemssen (T Ziemssen)